NCT00790751

Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil (TA-1790) in Subjects With Generalized Erectile Dysfunction

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 646 (actual)
• Sponsor: VIVUS LLC · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is being conducted to compare the safety and efficacy of 3 doses of avanafil to placebo in men with mild to severe erectile dysfunction.

Conditions

• Erectile Dysfunction

Interventions

Type	Name	Description
DRUG	placebo	30 minutes orally prior to initiation of sexual activity
DRUG	avanafil	30 minutes orally prior to initiation of sexual activity
DRUG	avanafil	30 minutes orally prior to initiation of sexual activity
DRUG	avanafil	30 minutes orally prior to initiation of sexual activity

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-08-01
• Completion: 2009-08-01
• First posted: 2008-11-13
• Last updated: 2012-07-11
• Results posted: 2012-06-28

Locations

41 sites across 1 country: United States